On December 24, 2024, the Ministry of Health granted a derogatory authorization for the marketing and use of disinfectants for intact skin prior to medical treatment containing 2% Chlorhexidine Digluconate as the active ingredient in 100-250-500 ml packaging, as biocides corresponding to previously authorized medical-surgical devices.

Subsequently, on February 26, 2025, the Ministry of Health issued a replacement decree, allowing the marketing and use of the aforementioned products under derogation, regardless of packaging size and no longer limited to 100-250-500 ml containers.

For more information, please refer to Decreto di Deroga del 26 febbraio 2025.

Cookie Policy
Manage Cookies
Cookies help us remember you, personalize your experience, deliver personalized commercial offers and show you more things we think you will like. For more information on cookies, please visit our cookie policy page.
Privacy Settings
These cookies enable us to offer you a personalized experience based on your navigation: